Refine by
Drug Interaction Articles & Analysis
32 news found
A critical aspect of drug development is understanding the interaction between drugs and biological systems, particularly for veterinary applications where species-specific responses can vary substantially. ...
Understanding the structure of DNA is essential for unraveling its functions and interactions with other molecules. High-resolution methods are therefore necessary to provide basic biomolecular insights, such as the structural characteristics of DNA, which will aid in understanding and allow for broader applications. ...
Biomedical Polymers Biomedical polymers have and still continue to play an important role in how we support and treat patients with various diseases through their use in tissue and blood interacting medical devices and drug delivery systems. Electrofunctional Polymers Conducting electroactive polymers such as polypyrroles, polythiophenes and polyanilines are a ...
This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce the need for animal testing and ultimately transform the future of medicine. ...
In recent years, the development of nanotechnology has had a tremendous impact on the development of novel nano-drug delivery systems. Various organic or inorganic materials have been used to prepare nano-drug delivery systems for safe and effective cancer therapy. PLGA-based drug delivery systems have attracted great interest because they can ...
It plays a crucial role in drug design and screening, as it enables modeling and prediction of interactions between proteins and small molecules, allowing customers to better understand drug mechanisms of action and optimize candidate compounds. CD ComputaBio’s Protein-Small Molecule Docking service utilizes state-of-the-art computational ...
The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...
The Cellworks platform uses computational biosimulation to model signaling pathways, master regulators, hallmark behaviors of cancer, and drug interactions with each patient’s unique disease network. Biosimulation stratifies treatment options according therapeutic impact and enables precision clinical trials that promises to transform the ...
Although the drugs themselves are complicated, it is urgent to develop techniques to characterize glycosylation in order to better evaluate their effects. One of the most significant post-translational modifications during protein characterization is glycosylation. It affects the drug's biological activity, serum half-life, stability, and immunogenicity, which ...
The field of protein DNA/RNA interactions is an expanding area of research. These interactions affect fundamental processes and as a result, relevant protein DNA/RNA processing complexes and their associated mechanisms provide interesting therapeutic targets to researchers. ...
LYTGOBI previously received breakthrough, orphan drug and priority review designations from the FDA. PRINCETON, N.J., September 30, 2022 – Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved LYTGOBI® tablets for the treatment of adult patients with previously treated, ...
We know that a drug substance is usually more stable by itself than in a formulation with excipients. Inappropriate dosage forms can interact with drug substances and in worst cases can even cause drug degradation,” says the Marketing Chief of CD Formulation. ...
“We are excited to partner with Total Brain to combine the power of their high-dimensional data with our drug prediction engine to open new doors for drug discovery specifically addressing neurological conditions – something that has never been explored this way before,” said Dr. ...
THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...
CD BioSciences, a leading customer-focused biotechnology company based in New York, recently introduces a series of GPCR Drug Discovery services to customers in their GPCR drug discovery and development projects. ...
“With this landmark achievement of our first approved drug, we have taken a monumental step toward our mission of bringing transformative medicines in neuroscience to patients using our AI platform. ...
(Nasdaq: GANX) (“Gain”), a biotechnology company transforming the drug discovery paradigm with structurally targeted allosteric regulators (STARs) identified with its proprietary computational discovery platform, today presented new pre-clinical data from its Gaucher Disease (GD) program. ...
” Gain Therapeutics is leading the wave of innovation in the field of allosteric drug discovery and is one of the pioneers in the field of computational biology. ...
Neuroscience and Beyond: Harnessing Computational Technology and Allosteric Modulators to Drug the Undruggable BETHESDA, Md., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. ...
Excipients usually play important and diversified roles in drugs. They interact with the active pharmaceutical ingredients (APIs) to improve the performance of the drug, for example, to promote drug absorption, to reduce viscosity, or to enhance solubility. ...